Oric Pharmaceuticals, Inc. ORIC Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Oric Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oric Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oric Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets?
- Oric Pharmaceuticals, Inc. (ORIC) reported deferred tax assets and other non-current assets of $6.6M in Q1 2026.
- How has Oric Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
- Oric Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets decreased by 21.1% year-over-year, from $8.37M to $6.6M.
- What is the long-term trend for Oric Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Oric Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets has grown at a 86.8% compound annual growth rate (CAGR), from $319K to $7.25M.